the focus will largely be on the data, but CHM would have been mentioned as the sponsor and you only really need one mention because anybody interested in it will look for that specifically. It's not like advertising where it's a bit of product placement.. the more consumers see it, they may just subconsciously want to buy it!
these conferences are attended by all sorts of people across investment through to medical staff... those in the investment field will know exactly what to look for, and note who the sponsor is. And if they missed it, they can contact the person who presented or the SNO... or simply google it
It's our first entry into the SNO and its early data.. whilst promising, it's unpredictable who the market will react... from experience it takes time for these type of things to filter through, and these high risk investments are quite niche and don't typically attract large funds..
I think our entry into the SNO in 2022 will be very different.. we may be at the back end of our phase 1 trial with a lot more data.
CHM Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)